"Let me play Devil's Advocate for a Minute..."
Important to note before reading this:
I am a highly invested and LONG investor who believes in the product and the science.
I am confident that Vascepa will turn into a HUGE and SUCCESSFUL product...
Let me play Devil's Advocate for a Minute:
1. A Company called GSK has a product called Fish Oil.
2. The Company markets and sells it successfully for years.
3. A new Company comes along, takes their product, cleans it up
a bit, then calls it something else and wants to sell it to
everyone and call it their very own idea.
Here is what the FDA has done so far:
1. Approve Vascepa
2. Say it is not a 100% new creation
3. Gave it 3 years + 30 months of protection
4. Asked the Company to continue with its testing to see if it
reduces Cardio Vascular Events
5. Said it is VERY interested (via AdCom participants) to see the
outcome of the long term (Reduce-It) testing
6. Said it is willing to approve Anchor if it proves it can do
more than Reduce Trigs
It appears from this perspective that the FDA believes in the product yet wants to be sure to protect the creation of the original product.
NOW: From another perspective...
1. How would this board react if the FDA completely rejected the
product from the very beginning?
2. How would this board react if the FDA allows another product
that cleans Vascepa up a little bit more and OK's it?
3. How would the board feel if the FDA said: You cannot create and
use this product knowing GSK's product is out there and they
can clean theirs up a bit more and do the very same as Vascepa?
4. How would the board feel if the FDA told Amarin to stop Reduce-
It knowing GSK could clean up their product and successfully
run the same testing as Reduce-It?
In short:
It looks like the FDA is allowing Vascepa even though it closely resembles GSK's product, it is allowing Vascepa to exist and sell, and it is asking (via AdCom) to continue testing to see if it will Reduce CVE's... It is also allowing Vascepa to do additional testing for other conditions like Dry Eye, Inflammation...
It ALL sounds Great to me...
Could the FDA just be protecting GSK's hard work YET know GSK's product is in the past and about to be completely over-run by Vascepa?
This is an interesting perspective full of Positive...
All I read on this board is what we as investors do not have and how we've been screwed...
What we do have is an excellent product on an excellent path with NO failure and is a safe product making slow and careful headway into Big Pharma's world...
IF Vascepa proves to be successful beyond everyone's dreams, why expose yourselves to the continued negativity of the "leaders" of this board?
IF Vascepa fails to prove any positive CVE reduction with Reduce-It, then where will all the "Let's Kill the FDA" people on this board end up then and how much value will the current "Kill position" be worth (then)?
I will end with this as I have before...
As Warren Buffet said:
Do not invest in a company unless you are willing to stay invested for 10 years or more and do not invest money you will need during the sane time!
In closing and to repeat:
I am a highly invested and LONG investor who believes in the product and the science.
I am confident that Vascepa will turn into a HUGE and SUCCESSFUL product...
...in good time while hitting a few bumps in the road!
The BEST products go thru the most rigorous testing, challenges, and scrutiny...
...and ALL of the best products succeed!
